ROEN Surgical’s AI-driven Zamenix robot debuts in Thailand.
ROEN Surgical successfully conducted its first international clinical live demonstration of the Zamenix AI-based kidney stone surgery robot in Bangkok, Thailand, during the International Robotics and Urology Symposium (RIRS2025) held at Ramathibodi Medical University Hospital on January 20–21.
Showcasing AI Innovation in Kidney Stone Surgery
The Zamenix Live Surgery, held on January 21, marked its debut in Asia, drawing significant interest from Southeast Asian medical experts. The region’s high incidence of kidney stones, influenced by climate and mineral-rich water, underscores the need for advanced solutions like Zamenix.
Key Features of Zamenix:
- AI-driven precision: Incorporates respiratory compensation, endoscopic path regeneration, and stone size guidance.
- Minimally invasive: Utilises a 2.8mm flexible endoscope to remove kidney stones without incisions.
- Enhanced safety and efficiency: Designed to handle complex cases, such as narrow ureters or stones in hard-to-reach locations.
During the symposium, six Thai patients underwent live demonstration surgeries, led by Prof. Chinnakhet Ketsuwan of Ramathibodi Hospital, in collaboration with Prof. Cho Sung-Yong of Seoul National University Hospital and ROEN Surgical.
Expanding Zamenix’s Global Reach
This live event follows the signing of an Indonesian copyright agreement earlier this year, strengthening ROEN Surgical’s foundation in the Asian market. CEO Dong-Soo Kwon said:
“We aim to promote the excellence of Korean surgical robots globally, with a focus on the high potential of Zamenix in Asia.”
Follow MEDWIRE.AI for updates on robotic innovations and global healthcare advancements!
